← All trials
NCT05807529
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 3, 2022
- Primary completion
- Dec 31, 2024
- Completion date
- Dec 31, 2024
- First posted
- Apr 11, 2023
- Last posted
- Jun 22, 2023
- Enrollment
- 136
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Orient Europharma Co., Ltd.Lead sponsor
- Government of TaiwanOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.